A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

About the study

WAYFIND-R is a registry that aims to capture high-quality real-world data linking next-generation sequencing, treatments and outcomes from cancer patients diagnosed with a solid tumour. The WAYFIND-R has three main overarching objectives: 1. To provide a platform to support the design and conduct of clinical and epidemiological research; 2. To develop an evidence-generation platform to better understand health outcomes and cancer care processes; and 3. To characterize the treatments and clinical course of solid tumor cancers in patients who have undergone NGS testing.

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria:

Participant is an adult (according to the age of majority as defined by local regulations)
Participant is currently diagnosed with any type of solid tumour cancer, at any stage of the disease, at the enrollment date (informed consent date)
Participant has undergone NGS testing, no longer than 3 months prior to the enrollment date, irrespective of the availability of test results
Informed consent has been obtained from the participant or legally authorized representative, as per local regulations

EXCLUSION CRITERIA

Exclusion Criteria:

-Participant has a prior or current diagnosis of haematological malignancy

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details

Contition

Solid Tumours

Age (in years)

18+

Participants needed

15000

Est. Completion Date

Dec 31, 2026

Treatment type

Observational [Patient Registry]

Sponsor

Hoffmann-La Roche

ClinicalTrials.gov identifier

NCT04529122

Study number

MX39897

Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?